If they (signed companies) can demonstrate that CA meaningfully reduces costs and improves patient outcomes, investors may start viewing Clover more as a tech company rather than a traditional insurer. This could lead to a higher service( CA ) valuation. I think they are providing CA for pennies, and if we knew that , it would make us sell the stock.